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The C. elegans NMD transcriptome <p>Th  high-resolution transcriptome of wild-type and nonsense-mediated decay (NMD) defective C. elegans during development reveals insights into the NMD pathway and it’s role in dev lopment.</p>
Abstract
Background: While many genome sequences are complete, transcriptomes are less well
characterized. We used both genome-scale tiling arrays and massively parallel sequencing to map
the Caenorhabditis elegans transcriptome across development. We utilized this framework to
identify transcriptome changes in animals lacking the nonsense-mediated decay (NMD) pathway.
Results: We find that while the majority of detectable transcripts map to known gene structures,
>5% of transcribed regions fall outside current gene annotations. We show that >40% of these are
novel exons. Using both technologies to assess isoform complexity, we estimate that >17% of
genes change isoform across development. Next we examined how the transcriptome is perturbed
in animals lacking NMD. NMD prevents expression of truncated proteins by degrading transcripts
containing premature termination codons. We find that approximately 20% of genes produce
transcripts that appear to be NMD targets. While most of these arise from splicing errors, NMD
targets are enriched for transcripts containing open reading frames upstream of the predicted
translational start (uORFs). We identify a relationship between the Kozak consensus surrounding
the true start codon and the degree to which uORF-containing transcripts are targeted by NMD
and speculate that translational efficiency may be coupled to transcript turnover via the NMD
pathway for some transcripts.
Conclusions: We generated a high-resolution transcriptome map for C. elegans and used it to
identify endogenous targets of NMD. We find that these transcripts arise principally through
splicing errors, strengthening the prevailing view that splicing and NMD are highly interlinked
processes.
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Identifying genes whose mRNA expression is perturbed in a
mutant can yield great insight into a wide range of biological
problems. For example, comparing gene expression in wild-
type organisms with that seen in mutants can be used to iden-
tify the targets of transcription factors or signaling pathways
[1], to organize genes into modules [2-7], and to order genes
in pathways [8,9]. Recently, genome-scale tiling arrays and
massively parallel sequence analysis of transcriptomes have
emerged as powerful new tools for transcriptome analysis
[10-14]. Both rely on the availability of high quality genome
sequence, and both offer the promise of transcriptome analy-
sis at unprecedented depth and efficiency.
Each technology has different strengths. In the case of tiling
arrays, the entire transcriptome can be queried at the same
depth in a single hybridization, making it a very cost-effective
way to achieve excellent coverage. However, the resolution
with which any transcript can be mapped is limited by the res-
olution of the array (which for most complex genomes is not
at single base-pair resolution) and, furthermore, while one
can rapidly identify the regions of the genome that corre-
spond to mature transcripts, the arrays contain no implicit
information about how these are connected. Deep sequencing
of the transcriptome on the other hand generates data at sin-
gle-base resolution. While the sequence reads from all cur-
rent technologies are short (typically 35 to 70 bp), it is
possible to assemble these into longer contiguous reads and
to link these contigs together. However, since the range of
gene expression extends over many orders of magnitude,
achieving good coverage for a complex transcriptome is still
costly, and assembly of the data is still computationally inten-
sive.
Since tiling arrays and sequencing have complementary ben-
efits for transcriptome analysis, we decided to use both tech-
nologies to examine the Caenorhabditis elegans
transcriptome across a series of developmental stages. The C.
elegans genome is completely sequenced and while it con-
tains a similar number of genes as the human genome, it is
much more compact - around 27% [15] of the worm genome
is coding compared with 1.5% [16] in humans. Genome anno-
tation is generally of high quality in the worm; the genome is
relatively small (approximately 100 Mb compared with
approximately 3 Gb in human) and unrepetitive, making both
tiling- and sequence-based approaches comparatively
straightforward in the worm. Both technologies allow exami-
nation not only of levels of gene expression but also of splice
changes across development; they also allow identification of
novel transcripts that do not lie in annotated gene structures.
They thus provide an unbiased and rich view of the changing
transcriptome across development and our immediate goal
was to map the wild-type transcriptome at good coverage and
resolution and, thus, to provide a framework to analyze per-
turbations of the transcriptome in mutants.
In addition to mapping the wild-type transcriptome across
several developmental stages, we wished to assess the useful-
ness of these data for examining how the transcriptome is
perturbed in mutant animals. To this end, we used both tiling
arrays and sequencing to examine the transcriptome of
worms defective for nonsense-mediated decay (NMD), iden-
tified in animals by Hodgkin et al. [17] and reviewed in
[18,19]. The central cellular role of the NMD pathway is to
prevent the expression of prematurely truncated proteins,
which are likely to have deleterious consequences. The NMD
pathway recognizes transcripts containing premature termi-
nation codons (PTCs) and targets them for degradation, thus
eliminating them from the cell [20]. The role of the NMD
pathway in eliminating PTC-containing transcripts is highly
conserved and indeed many of the components are shared
from yeast to human (see [21,22] for reviews), including the
core components SMG-2, SMG-3 and SMG-4 (Upf1-3 in Sac-
charomyces cerevisiae).
The PTC-containing transcripts that are targets for NMD rec-
ognition and degradation arise from three principal sources
[21,23-27]. The first occurs from transcripts deriving from
genes containing nonsense mutations, whether inherited or
somatic. However, nonsense mutations play a clear role in
many human genetic diseases, and in several of these, NMD
has been shown to affect the severity of the disease phenotype
and, thus, this class of target, though rare, has key medical
importance [28]. The second class comprises transcripts that
contain PTCs that arise during alternative splicing - either
retention of introns or errors in splice site selection [29-32].
Finally, transcripts can be targeted by NMD despite having no
PTCs in the principal open reading frame (ORF); instead,
these transcripts contain a short ORF upstream of the true
start ATG, known as an upstream ORF (uORF). The stop
codon of this uORF is recognized as a premature stop codon
and the transcript is thus recognized as an NMD target.
Recently, genome-scale studies using standard expression
microarrays have identified endogenous transcripts that are
targets of NMD in yeast [33,34], Drosophila [35,36], and
humans [37-39]. In all three organisms examined, approxi-
mately 10% of genes give rise to a transcript that is targeted
for degradation via the NMD pathway, a surprisingly large
number [40].
Much is thus known already about NMD: the molecular com-
ponents of the NMD pathway are well-characterized, many of
the molecular features that cause a specific transcript to be
degraded via the NMD pathway are known, and many endog-
enous transcripts are found to be affected by NMD. However,
other than in yeast [32] no genome-scale studies have exam-
ined the effect of NMD on wild-type transcriptomes with the
resolution that either tiling arrays or transcriptome sequenc-
ing can provide. We thus set out to compare the transcrip-
tomes of wild-type animals with that of worms that are
defective for NMD using both tiling arrays and deep sequenc-
ing to determine whether the increased resolution of suchGenome Biology 2009, 10:R101
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the transcriptome of normal developing worms.
Results and discussion
Outline of approach and overview of data
Both genome-scale tiling arrays and deep sequencing
approaches were used generate a high resolution, high cover-
age 'reference transcriptome' for C. elegans to use as a tool to
guide analysis of perturbed transcriptomes such as those of
mutant animals. At the time of initiating these studies, there
was a great difference in the cost to analyze any specific RNA
sample by tiling arrays or by deep sequencing, and we thus
chose to use tiling arrays as our primary method to map the
transcriptome across multiple developmental stages, and
deep sequencing to validate the tiling data and to refine the
resolution of the transcript mapping at a more limited
number of developmental stages. Combining these data in
this way combines the cost-effectiveness of tiling with the
higher resolution of sequencing to generate a high quality
transcriptome map.
For our tiling analysis, we purified total RNA from wild-type
N2 animals at four different stages of the C. elegans life-cycle
(larval stages L3 and L4, young adults, and gravid adults). For
each developmental stage, RNA samples were prepared in
triplicates and hybridized individually to genome-scale tiling
arrays - these have a 35 bp resolution and allow an unbiased
view of the majority (70%) of the genome. We initially exam-
ined these data to assess coverage and to compare data qual-
ity between tiling and sequencing. At any single
developmental stage, we detect expression of around a third
of all predicted genes on tiling arrays (see Materials and
methods; Table S1 in Additional data file 1); across all exam-
ined stages, we detect approximately 50% (9,515 out of 19,169
annotated genes in WS150 release of Wormbase [41]) of
genes. This is comparable to the detection sensitivity of con-
ventional microarrays. We find that approximately 95% of
transcribed features (so-called 'transfrags', the individual
contiguous regions of the genome that are transcribed; see
Materials and methods and [11,13] for definition) map to cur-
rently predicted transcripts (Table S2 in Additional data file
1), a far higher proportion than that observed in either Dro-
sophila [42] or human [10]. We note that while the propor-
tion of novel transfrags is far lower in the worm, this is in
keeping with previous results [12] and is broadly as expected
for the worm genome given the far higher proportion of pre-
dicted coding sequence relative to that found in many other
animal genomes. In addition, this low proportion of novel
transcribed regions identified as transcribed indicates that
genome annotation and gene prediction in the worm is of
generally excellent quality.
To validate our tiling data, we used Illumina sequencing to
directly sequence the transcriptome of two developmental
stages (L4 and young adults) along with mixed stage worms
and compared these sequence data to the tiling data. We gen-
erated approximately 225 million individual reads, of which
approximately 217 million (85%) could be uniquely assigned
to the genome using Mapping and Assembly with Qualities
(MAQ; Table S3 in Additional data file 1) [43]. Of these
uniquely mapped reads, approximately 94% map entirely
within known transcripts (approximately 85% of all reads
map entirely within known exons and approximately 9% span
exon-exon junctions), a number that corresponds closely to
that seen by tiling (95% of transcribed regions map to known
transcripts by tiling). We compared gene intensities deriving
from both tiling and sequence data and find very tight corre-
spondence between these measurements (Figure 1a), suggest-
ing that both methods give accurate estimates of levels of
mRNA expression. Finally, we compared the sets of genes
whose expression is detected by tiling and by sequence analy-
sis and find that approximately 90% of genes that have
detectable expression by tiling can also be detected by
sequence (Figure 1b). We thus show that the two technologies
provide accurate and complementary surveys of the tran-
scriptome, allowing direct comparison with the transcrip-
tomes of mutant animals.
Novel transcribed regions of the C. elegans genome
As described above, we find that approximately 95% of the
transcribed regions detected by either tiling array or sequence
map to predicted transcripts (Additional data file 2) - a repre-
sentative region of the genome is shown in Figure 1c. We next
examined whether both technologies detected the same novel
transcribed regions and whether these novel regions are likely
to represent entirely new stand-alone transcripts (that is,
from potentially new genes) or rather are novel exons of pre-
viously annotated genes. We first identified all novel transf-
rags identified on tiling arrays at any developmental stage by
comparing the tiling data to WS150 gene models and asked
what proportion of these can be confirmed by sequence reads
(Figure 2a; Table S4 in Additional data file 1). Of the novel
transfrags found by tiling, approximately 60% can be
detected by sequence - since both technologies are very differ-
ent, these confirmed novel transfrags are likely to be real.
Note that while tiling arrays were used to analyze total RNA,
only poly-adenylated transcripts were sequenced to avoid
redundant reads of rRNA, and this is thus a lower estimate of
true novel transcripts identified by tiling. We note that two
other studies have appeared that also used sequencing to ana-
lyze the C. elegans transcriptome and we thus compared our
data with that produced by Hillier et al. [44], who also used
deep sequencing to examine the transcriptome at several
developmental stages (rather than Shin et al. [45] who exam-
ined only L1, a stage we did not look at). We find that the over-
lap is very significant at the gene level (Table S5 in Additional
data file 1) and at the level of transfrags (Table S6 in Addi-
tional data file 1), confirming the accuracy of all datasets.
Novel transfrags can either arise from entirely new tran-
scripts that have not been predicted or they could alterna-Genome Biology 2009, 10:R101
http://genomebiology.com/2009/10/9/R101 Genome Biology 2009,     Volume 10, Issue 9, Article R101       Ramani et al. R101.4tively be novel exons or previously predicted genes. In the
latter case, it should be possible to connect these novel trans-
frags to known gene annotations. To examine this, we used
Illumina paired end sequencing on poly-A+ RNA derived
from mixed stage populations of worms. We identified reads
mapping to novel transfrags and asked whether the paired
sequence read mapped to a known gene structure. In approx-
imately 60% of cases (Figure 2a), we could unambiguously
connect a novel transfrag confirmed by both sequence and til-
ing to a previous predicted transcript, suggesting that these
are novel exons (Figure 2b, c). Of such novel exons, 65% (20%
5' and 45% 3') are either 5' or 3' to the coding region of the
gene, consistent with a view that terminal exons are more var-
iable; therefore, predicting transcript ends is considerably
harder and more error prone than predicting internal coding
exons.
Finally, to further investigate the novel transfrags identified
by tiling, we compared our tiling data to multiple other gene
models in C. elegans. First, we examined the proportion of
Tiling array data and sequence-based data give similar views of the transcriptomeF gure 1
Tiling array data and sequence-based data give similar views of the transcriptome. (a) Gene intensities (left) and exon intensities (right) from the tiling data 
were binned at 0.1 increments of gene intensity (log2 scale) and compared with the intensities deriving from sequence data; there is a strong correlation 
(R2 = 0.95) between gene intensities derived from both technologies. YA, young adult.(b) Approximately 90% of the genes expressed based on tiling are 
also expressed in the sequence data in both stages sequenced. (c) Sample screenshot from Affymetrix Integrated Genome Browser illustrating how tiling 
array data and sequence data correspond to predicted gene structures. Tiling array data from four developmental stages (L3 and L4 larvae, YA and gravid 
adults (GA)) are shown in shades of blue. The predicted exons of unc-52 (ZC101.2) are shown at the top of the plot. Exons that are differentially spliced 
across development based on tiling data are shown in yellow. Regions corresponding to transfrags that do not overlap predicted exon structures are 
highlighted with purple bars. Sequence data for a single developmental stage (YA) is shown in red at the bottom of the figure; note that the regions 
identified as transcribed by sequencing correspond closely to those identified by tiling. Non-adjacent exon boundaries spanned by sequence reads are 
shown as green bars and the exons removed by the alternative splice shown in red below; the height of the green bar corresponds to the frequency with 
which the alternative splice events were detected.
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Novel transfrag annotationFigure 2
Novel transfrag annotation. (a) Using stage specific sequence data we were able to show that approximately 60% of the novel transfrags have sequenced 
reads mapping to them. We also show that 60% of these transfrags with sequence information can be connected to known gene annotation using paired-
ended sequence reads, where one read of the pair is anchored on the transfrag while the other overlaps a gene annotation. Examples of novel regions 
identified from our analysis, show (b) a new 5' exon and (c) a novel transcript. (d) Transfrags identified as novel in our tiling data based on WS150 of the 
genome annotation were compared against WS160, WS170, WS180 and WS190 models. We see that >30% of the transfrags that were novel based on 
WS150 are predicted to be exonic in later annotations (grey bars). Almost 50% of novel transfrags that also have sequence reads overlapping them are 
predicted to be exonic in later annotations (black bars). We can show annotation overlap for a further 15% (tiling alone - gray) or 25% (tiling with 
sequence data - black) when we compare the transfrags to TwinScan models.
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of Wormbase) that were still novel in later sets of gene models
(WS160, WS170, WS180, and WS190) (Figure 2d). We find
that approximately 30% (670 of 2,229) of transfrags that were
outside gene models in WS150 have since been incorporated
in newer gene models; 90% of those that are novel exons are
now confirmed in gene models. Of the remaining (approxi-
mately 70%; 1,530 of 2,229), we note that many map to alter-
native gene models outside the canonical C. elegans gene
models - for example, approximately 15% (204 of 1,530) over-
lap with Twinscan models. We believe that many of these
novel transfrags are likely to represent errors in standard
gene models, since other gene models predict many of them
relatively well. Thus, our data, like previous work [44,45],
may contribute to refining de novo gene models.
In total, then, we identified 10,073 (the unique non-overlap-
ping set from the four stages) novel transcribed regions rela-
tive to gene models in WS150 using tiling arrays. Most of
these (Table S4 in Additional data file 1) could be confirmed
by sequence and of those identified by both technologies,
approximately 30% appear to be novel exons of previously
annotated transcripts.
Alternative splicing detection using tiling arrays and 
transcriptome sequencing
Tiling arrays can be used to measure gene expression at the
level of mRNA. However, unlike conventional expression
arrays, tiling arrays can also be used to examine the expres-
sion of individual exons and their relative inclusion into tran-
scripts deriving from any gene. Changes in the relative
inclusion of an exon across development indicate changes in
splicing and we thus investigated the extent to which we could
identify splice changes across C. elegans development using
our tiling data. For each exon, we computed its normalized
intensity at each developmental stage based on tiling data.
The normalized intensity (NI) of any exon is the expression
level of the exon relative to the expression level of the gene
that includes it. An NI of approximately 1 for an exon indi-
cates that essentially all transcripts deriving from that gene
include that exon; an NI of approximately 0 indicates that this
exon is skipped from almost all transcripts deriving from that
gene. We note that just as gene expression levels measured by
tiling and sequence correlate very highly, this is also the case
for levels of expression of each individual exon (Figure 1a).
Prior to examining how the NI of each exon changes across
development, we compared exon inclusion as estimated by NI
from tiling with direct measurements of splicing from our
sequence data. We identified sequence reads that span exon-
exon junctions - we searched for these both between adjacent
exons and between non-adjacent exons (see Materials and
methods). Note that reads spanning exon-exon junctions are
far more rare than those mapping internally to exons since
the effective target is smaller and achieving high coverage of
exon junctions thus requires substantially more sequence
depth than that required simply to detect gene expression;
furthermore, identification of such exon spanning reads is
highly sensitive to correct exon junction predictions. To
examine the extent to which NI measured from tiling data
gives a verifiable measure of splice variation, we identified all
exon triplets that appear 'cassette-like' from our tiling data
(see Figure 3a for schematic and Figure 3b for an example) -
that is, triplets where exons A and C have NI of approximately
1 and the middle exon B has an NI of <1. In such cases, we
would infer that A and C are included in all transcripts and
that B is included at a lower rate due to exon skipping as
measured by its NI. This is the simplest test example. To test
whether the alternative splicing that we infer from tiling NI
data is accurate, we examined all such triplets to determine
how often we could identify reads that provide direct evidence
for skipping of exon B, identified by detecting sequence reads
spanning the junctions of A-C. These data are shown in Figure
3c and show that we can identify sequence reads, confirming
at least partial exon skipping for over 65% of exons with an NI
<0.2. This drops to approximately 50% for exons with an NI
<0.5; 688 exons have an NI <0.5, corresponding to 635
genes, and, based on these data, at least 50% of these alterna-
tive splicing events can be confirmed by sequence. We note
that the ability to confirm alternative splicing events based on
tiling arrays by sequence reads is highly dependent on read
depth and on the NI of the exon in question and this is thus
likely to be a considerable underestimate of the true quality of
the tiling-based splicing analysis.
Having established that normalized exon intensity can iden-
tify alternatively spliced exons with reasonable accuracy, we
searched for exons whose NI changes between any two devel-
opmental stages. A significant change in NI for an exon
between two stages indicates a shift in isoform levels for the
gene in question. Note that we cannot infer the isoforms
themselves, but only identify that they have changed based on
changing NI. We find that approximately 5% (459 of 9,515) of
expressed genes contain at least one exon whose NI changes
by over 2-fold between any two developmental stages - that is,
at least approximately 5% of genes change their relative iso-
form levels across development. While approximately 18%
(based on WS150 release of the genome annotation) of worm
genes are currently annotated to have multiple isoforms, this
is the first genome-scale analysis of how isoforms change
across development, although the identification of 5% of
genes whose isoform patterns change across development is
highly likely to be an underestimate.
Identification of endogenous targets of nonsense-
mediated decay
As described above, we have combined tiling arrays and deep
sequencing to construct a high-resolution reference tran-
scriptome for wild-type animals across several developmental
stages. We wished to use this to examine how the transcrip-
tome is perturbed in mutant animals. Specifically, we were
curious to see whether the high resolution of our transcrip-Genome Biology 2009, 10:R101
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dent using standard gene expression microarrays. As a test
case, we chose to examine the transcriptome of worms defec-
tive for NMD. This was first identified in animals by Hodgkin
et al. [17] and is a highly conserved cellular program evolved
to prevent the expression of prematurely truncated proteins
(reviewed in Chang et al. [18]) The NMD pathway recognizes
transcripts containing PTCs and targets them for degradation
- thus, transcripts that are targets for NMD should have ele-
vated expression in cells that have no functional NMD path-
way. This has been used to identify endogenous transcripts
that are NMD targets in S. cerevisiae, Drosophila and human
cells [34,36-39,46]. We mapped the transcriptome of worms
that are defective for NMD using a combination of tiling
arrays and sequencing (exactly as was done for the wild-type
transcriptome above), and compare it to our wild-type refer-
ence transcriptome (Additional data file 3). This should allow
us first to identify the endogenous targets of NMD in C. ele-
gans, which has never been done at the genome-scale; sec-
ond, to examine the features of transcripts are endogenous
targets of NMD in C. elegans to see whether this is similar to
that found in other organisms; and finally to determine
Splicing changesFigure 3
Splicing changes. Normalized exon intensities (see Materials and methods) were calculated for all exons. (a) The set of cassette exons was determined 
using our tiling data as exons with an NI <0.8 (exon B). Cassette exons may also be indicated by the presence of sequence reads spanning the boundaries 
of the flanking exons (exons A and C). (b) An example of a typical cassette exon. (c) Exons were binned based on their NI (x-axis) and the percentage of 
these cassette exons that have sequence reads spanning the exonA-exonC junction were identified. At a NI <0.2 nearly 65% of the cassette events show 
an alternative exon read while 50% of all exons with NI <0.5 can be shown to have an alternative junction spanning read.
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map that are not seen simply by examining overall gene
expression.
We examined the transcriptome of smg-1(r861) mutant
worms - smg-1 encodes a central kinase in the NMD pathway,
is highly conserved in eukaryotes, and is absolutely required
for NMD in C. elegans [17]. We purified total RNA from smg-
1(r861) mutant animals at the same four developmental
stages (L3, L4, young adults, and gravid adults) examined in
the wild-type animals and hybridized these in triplicate to
genome-wide tiling arrays. We computed gene intensities as
for the wild-type transcriptome and could thus identify genes
whose expression levels are perturbed in the smg-1(r861)
mutants. We also used Illumina sequencing to examine the
smg-1(r861) transcriptome at two developmental stages to
check our tiling data. We find that just as gene expression lev-
els and exon expression levels were highly similar between til-
ing and sequencing in the wild-type transcriptome, they are
highly correlated for the smg-1(r861) data (Additional data
file 3).
Looking across all developmental stages, approximately 17%
(1,645 of 9,515) of all detectable genes differ in expression
level by at least 1.5-fold between wild-type and smg-1(r861)
worms and in the great majority of cases (approximately 75%
overall), transcript levels are higher in the smg-1(r861)
mutant, consistent with these being NMD targets. To confirm
that these are not somehow specific to the smg-1(r861) strain,
we also examined one time point (L4 larvae) in animals
mutant for SMG-5 [47], a key phosphatase in the NMD path-
way, and find that the great majority (318 out of 437 genes in
this stage; approximately 73%) of genes whose expression dif-
fers between wild-type and smg-1(r861) animals also differs
between wild-type and smg-5 (r860) animals [47], confirm-
ing the majority of these differences are indeed the result of
loss of NMD and are not somehow specific to smg-1(r861).
We thus estimate that at least 10% of genes produce a tran-
script that is elevated in an NMD mutant animal; this is likely
to be an underestimate. This is a very similar proportion to
that seen in yeast, fly, and human and suggests that while
genome complexity and transcriptional regulation is very dif-
ferent in these organisms, the proportion of genes whose
expression is affected by NMD is very similar. We next sought
to examine the features of the transcripts that have elevated
expression in the smg-1(r861) mutants.
Features of NMD-regulated transcripts in C. elegans 
identified from gene models
We have identified many genes whose expression is increased
in animals that have no functional NMD pathway. We note
that identifying a higher level of expression of any gene in a
NMD mutant does not mean that every transcript deriving
from that gene is an NMD target, nor can we be sure that the
effect is direct. However, what is clear is that all true endog-
enous NMD targets (ENTs) will have increased expression in
mutant animals where NMD is completely lost. We therefore
reasoned that transcript features associated with true NMD
targets will be enriched in the sets of transcripts that are more
highly expressed in the smg-1(r861) mutants even if some
expression changes are the result of downstream effects.
We examined the predicted transcript structures of all 1,645
genes showing higher expression in the smg-1(r861) animals
to identify enriched features. As shown in Figure 4, we find
strong enrichment for two features: the presence of an uORF
in the 5' untranslated region (UTR) upstream of the predicted
start ATG (Figure 4a; Additional data file 4) and 3' UTR
length (Figure 4c; Additional data file 4). The greater the
effect of loss of NMD on the transcript level, and the greater
the number of developmental stages for which we see this
change, the stronger the enrichment appears to be. This is
consistent with previous analyses in other organisms and
confirms that we can identify transcript features that appear
to be responsible for targeting endogenous transcripts by
NMD by searching for features that are enriched in tran-
scripts that are more highly expressed in the smg-1(r861) ani-
mals [24-27,36,48]. To identify this enrichment of uORFs
and longer 3' UTRs in ENTs, we relied exclusively on gene
models. We next wished to use our tiling and sequence data to
look at other transcript features. In particular, many PTCs are
introduced by splicing errors [29,31,32,40,49,50], including
intron retention and the incorrect retention or skipping of
exons, and we examined these individually and show exam-
ples in Figure 5.
Intron retention in NMD-regulated transcripts in C. 
elegans
We computed intensities from all annotated introns using
identical methods to those for computing exon intensities
(see Materials and methods). If there is detectable expression
of any individual intron, we conclude that it is being at least
partly retained in transcripts deriving from that gene; in the
vast majority of cases (>99%), such retention introduces a
PTC. We find that genes that have higher expression levels in
smg-1(r861) mutant animals are highly enriched for the pres-
ence of a retained intron (Figure 4b; Additional data file 4),
confirming that intron retention is a major cause of PTCs and,
hence, a feature of ENTs in the worm. This analysis to identify
intron-containing ENTs is relatively insensitive, however; if
only a very small fraction of transcripts deriving from any one
gene retain an intron, this will result in only a very small dif-
ference in gene expression between wild-type worms and
smg-1(r861) mutants and we would thus not detect this. In
addition to asking 'of the genes with increased expression in
smg-1(r861) mutants, what proportion have retained
introns?', we can ask 'are there introns whose expression lev-
els differ between wild-type and smg-1(r861) mutants?' This
is a far more sensitive analysis since it can pick up introns that
are retained in only very low fractions of transcripts coming
from any gene but whose retention causes NMD to target
those rare transcripts. We find 1,640 introns that have at leastGenome Biology 2009, 10:R101
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Features predisposing transcripts to NMDigur  4
Features predisposing transcripts to NMD. Indicated are the percentage of genes exhibiting the measured feature (y-axis), the number of stages at which 
this is observed (x-axis) and the fold increase in gene intensity in smg-1(r861) over N2 (z-axis, log2 scale). In each case the average background occurrence 
of the feature is indicated by the grey square. The measured features are: (a) percentage of genes with a uORF; (b) percentage of genes with expressed 
introns; (c) average 3' UTR length; (d) the total percentage occurrence of the above three NMD features for the set of over-expressed genes. The plots 
show a clear positive correlation between the feature examined and the increased effect of NMD on the transcripts.
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Examples of NMD featuresFigure 5
Examples of NMD features. (a) Example of a gene upregulated in smg-1(r861) and showing transcript expression from the upstream ORF. (b) Exon4 of 
rsp-1 is alternatively spliced in smg-1(r861) animals, observed as a change in the NI of the exon between the two stages. (c) The retention of an intron 
expressed at very high levels in the mutant, which also has a higher gene intensity. (d) A retained intron, where the gene intensity remains similar between 
the mutant and wild type (that is, a gene for which only a small proportion of transcripts retain the intron).
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6); these correspond to transcripts from 1,274 genes. In
almost all cases, while the intron-containing transcripts are
NMD targets, they are expressed at very low levels compared
to the overall gene intensity and the great majority of genes
with such introns thus have essentially identical expression in
wild-type and smg-1(r861) animals.
We conclude that precise intron excision is relatively efficient
in the worm since the great majority of introns are correctly
excised and thus undetectable. However, at least 7% (1,274 of
20,000) of genes produce transcripts in which an intron has
failed to be excised and that are ultimately degraded by NMD
in wild-type animals. Intriguingly, we find that the retained
introns are not a random set, but instead share certain fea-
tures. Most particularly, we notice a decrease in usage of the
canonical TTTCAG splice site consensus at the 3' end of these
introns and a corresponding increase in the usage of less com-
mon splice sites. While nearly 75% of annotated introns con-
tain the canonical TTNCAG, only 55% of the expressed
introns have these 3' splice sites (P-value = 0.004) [51]. We
thus suggest that the number of errors associated with exci-
sion of introns flanked by splice sites that closely match the
consensus sequences is far lower than for introns that have
more divergent splice sites. This is similar to the relationship
between diminished 5' splice donor and branch point consen-
sus and intron retention leading to NMD as observed in yeast
[32].
Splicing changes in NMD-regulated transcripts in C. 
elegans
It is becoming increasingly apparent that splicing and NMD
are two highly linked processes, with almost entire families of
splicing factors being alternative splicing-dependent NMD
Intron expression is upregulated in NMD mutantsFigure 6
Intron expression is upregulated in NMD mutants. Of the introns expressed in both N2 and smg-1(r861), 1,642 (45%) introns are ≥2-fold upregulated in 
smg-1(r861). Nearly 75% of the expressed introns have higher expression (>1 in the x-axis) in smg-1(r861) compared to wild type.Genome Biology 2009, 10:R101
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in splicing between wild-type and smg-1(r861) animals at the
level of exon intensity. As described above, we computed NIs
for all cassette exons in each of the developmental stages in
the smg-1(r861) animals and compared these NIs to those of
each exon in wild-type animals. A difference in NI between
wild-type and smg-1(r861) animals for any exon indicates a
difference in overall levels of inclusion of that exon in the
entire set of transcripts deriving from that gene in worms
lacking NMD; this may be a direct or indirect effect of loss of
NMD. In the case of direct effects, the exact same set of tran-
scripts is synthesized in wild-type and smg-1(r861) animals;
however, some splice variants contain PTCs and are thus
degraded by NMD in wild-type worms. The difference in NI
for an exon between wild-type and smg-1(r861) is thus due to
the failure to degrade these PTC-containing isoforms in smg-
1(r861) animals. Retention of these PTC-containing isoforms
in smg-1(r861) animals will affect overall gene intensity;
hence, in the case of splice changes that are the direct effects
of NMD, not only will the NI of any exon be perturbed in the
smg-1(r861) mutant, but the overall gene intensity will also
be affected. Alternatively, a change in NI for an exon between
wild-type and smg-1(r861) might be completely indirect,
some downstream consequence of loss of NMD. In such
cases, the difference in NI for an exon is due to a difference in
the isoforms synthesized between wild-type and smg-1(r861)
mutants. In these indirect cases, the NI difference reflects a
difference in splicing between wild-type and smg-1(r861)
mutants rather than a difference in transcript turnover/
retention, and there will thus be no accompanying difference
in gene intensity between wild-type and smg-1(r861)
mutants. We thus distinguish direct from indirect effects of
NMD on splicing patterns by assessing whether there is a
gene intensity change accompanying any splice change that
we see; if there is a concomitant change in gene expression,
we deduce that the splice change is a direct effect of NMD.
We find that 485 genes have an exon whose NI differs
between wild-type and smg-1(r861) mutants by 2-fold or
more. In 350 of these 485 genes (72%) we find that the vary-
ing exon has an NI of 0.5 or more in the smg-1(r861) mutant;
that is, in animals that have lost NMD, that exon is present in
at least 50% of the transcripts deriving from that gene. How-
ever, only a minority of these genes (approximately 22%)
show any difference in expression level in the NMD mutant
animals. This is surprising - if these splice changes were the
result of retaining transcripts with PTCs, we would expect a
substantial difference in overall gene expression levels in the
mutant. This suggests that many of the NI changes seen are
likely to be indirect effects of loss of NMD (since transcripts
are not NMD targets with or without the varying exon) and
may be indicative of a more general perturbation in splice site
selection in the NMD mutants. One possibility to explain indi-
rect effects on splicing in NMD mutants is that NMD is affect-
ing expression of splice factors themselves and there is
previous evidence to suggest this may be true. One particular
class of genes whose expression is affected by NMD com-
prises the rsp genes that encode the SR family of splice factors
[30,40,50]. Indeed, when we examine our tiling data we see
that seven of the eight C. elegans rsp genes give rise to NMD-
targeted transcripts that have retained introns and we con-
firmed all these events by RT-PCR (Additional data file 5). We
also find that the SR and hnRNP families of splice factors are
over-expressed in the smg-1(r861) mutants based on both
our tiling and sequence data (Table S7 in Additional data file
1), and wanted to extend this analysis to other splice factors to
see if this is generally true.
We examined a manually curated list of all well-annotated
splice factors (Table S8 in Additional data file 1) to see if NMD
has an effect on expression of other splice factors and find
that while only 13% (2,631 of 20,000) of all genes have an
exon with an NI differing by 1.5-fold or more between wild-
type and smg-1(r861) worms, approximately 33% (44 of 132;
P-value < 0.0001) of splice factors have an exon with an NI
differing by 1.5-fold. This is a strong enrichment and accords
with previous findings [29,30,39,40,50,53]. Crucially, the
great majority of these differences in NI in splice factors in
smg-1(r861) worms appear to be direct consequences of the
loss of NMD - while only 30% of genes with strong differences
(3-fold or higher) in NI between smg-1(r861) and wild-type
show any difference in expression level in the NMD mutant
animals, over 90% of splice factors with similar NI differences
(3-fold) show increased expression levels (1.5-fold or higher)
in the smg-1(r861) worms. We thus propose that the majority
of splice differences between wild-type worms and worms
defective for NMD are indirect; however, in the case of splice
factors themselves, most splice differences are highly likely to
be direct, the immediate result of expression of PTC-contain-
ing isoforms of these genes.
Translational initiation efficiency at the true start ATG 
affects NMD targeting of transcripts
In the preceding sections, we described the identification of
transcript features that are enriched in genes that have
increased expression in animals that have no functional NMD
pathway. One of the strongest features associated with NMD-
regulated transcripts in the worm is the presence of an uORF
(see above). Intriguingly, however, while ENTs are enriched
for the presence of uORFs, many transcripts that have uORFs
are not affected at all by NMD - how does the organism dis-
criminate between these? An obvious explanation for this
might be that the extent to which NMD targets an uORF-con-
taining transcript is strongly linked to the efficiency with
which the uORF is translated. In this model, in the cases
where the uORF is translated efficiently, the NMD effect is
strong; in transcripts where the uORF is not translated effi-
ciently - and thus is not 'seen' by the cell - NMD has little
effect. One key determinant in the rate of translational utili-
zation of any start ATG is the sequence surrounding the ATG;
the best known of these is the Kozak consensus. We thus
examined the sequences surrounding the start ATG of theGenome Biology 2009, 10:R101
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those that are not (see Materials and methods) to detect any
differences in sequence composition. We find no difference
between these two sets of genes. Intriguingly, however, when
we examined the sequences surrounding the predicted true
start ATG for both ENTs and transcripts unaffected by NMD,
we found a clear difference. While 60% of transcripts with
annotated 5' UTRs have an adenine at the -3 position (con-
sistent with a Kozak consensus [54]), in the case of the NMD-
regulated genes the percentages of adenines at this position
are 53%, 47% and 43% for genes with 1.2-fold, 1.5-fold and
1.7-fold higher expression in smg-1(r861), respectively (Fig-
ure 7). Thus, a weaker Kozak consensus at the true ATG cor-
relates well with a higher effect of NMD on transcript
regulation. This fits with a scanning model for ATG selection
whereby the start ATG is identified following a pioneering
round of translation - if the true ATG is in a strong Kozak con-
sensus, the uORF ATG may not be subsequently used and the
transcript may thus evade NMD. We note that this effect is
slight, and is poorly predictive - many uORF-containing tran-
scripts that evade NMD do not have a strong Kozak at the true
start ATG, and vice versa. Thus, this slight trend cannot
explain the bulk of the variation in NMD targeting for all
examples of uORF-containing transcripts but it does suggest
a highly speculative model where a Kozak consensus at the
true ATG may influence both translational efficiency and
transcript abundance.
Conclusions
Both genome-scale tiling arrays and new generation sequenc-
ing technologies can be used to examine the transcriptome at
great depth and coverage. We used both technologies to make
a 'reference' transcriptome for C. elegans, examining several
different developmental stages of wild-type worms using high
resolution tiling arrays and validating the data using deep
sequencing. Our principal aim was not to make an exhaustive
and complete map of the C. elegans transcriptome, but rather
to generate a high-resolution scaffold that can be used to
identify subtle perturbations of this transcriptome in mutant
animals. Nonetheless, mapping the wild-type transcriptome
itself identified a number of interesting findings and novel
features.
First, we find that both sequencing and tiling analysis yielded
very similar transcriptome maps, as had previously been
found in Schizosaccharomyces pombe [14]. The transcribed
regions identified corresponded extremely well between
these two technologies, and the levels of expression of either
genes or individual exons were very similar. Since the meth-
odologies underlying tiling arrays and sequencing are very
different, this suggests that both methods are providing accu-
rate maps of the transcriptome and expression levels. Second,
we used both methodologies to assess levels of alternative
splicing in the worm, and to identify changes in splicing
across development. We find that most of the alternative
splicing events inferred from tiling arrays can be directly val-
idated by sequence reads spanning exon junctions and find
that at least 5% of genes have major changes to their isoforms
between any two developmental stages. This suggests that
using either technology, or a combination of both, to examine
perturbations in alternative splicing either in different condi-
tions or different mutant backgrounds will be very powerful.
Finally, we used tiling arrays to identify over 10,000 regions
of the C. elegans genome that are transcribed but lie outside
current canonical gene models. We find that over 60% of
these can be confirmed by sequence, suggesting that most of
these are real transcripts. Other gene finding programs such
as Twinscan predict many of these, indicating that there may
be a systematic bias against these specific transcribed regions
in the models used to build the current canonical gene mod-
els. We examined our sequence data and find that approxi-
mately 40% of these novel transcribed regions can be
connected to current gene models; these are thus novel exons.
The remainder likely represent entirely novel genes and their
Relationship between consensus Kozak sequence at the true start ATG for gene  affected by NMD compared with all genesFigure 7
Relationship between consensus Kozak sequence at the true start ATG 
for genes affected by NMD compared with all genes. In each panel the x-
axis corresponds to the sequence considered while the y-axis refers to the 
percent occurrence at each nucleotide position expressed as 'bits' using 
Weblogo [70]. The top panel (in yellow) shows the consensus among all 
transcripts with an annotated 5' UTR and reveals the importance of an 
adenine in the -3 position - this is the classic Kozak consensus. This 
occurrence of adenine at the -3 position decreases significantly with 
increased NMD regulation as is shown in the bottom panel (red). The 
significance of change in enrichment of the adenine at -3 between NMD 
regulated and all genes was determined by chi-squared test. Pval, P-value.
NMD upregulated (1.2 fold; in 4 stages; pval=0.013)
0
1
2
b
its
-5
A
T
-4 -3
G
A
-2
C
T
A
-1
C
AATG A
1 2 3 4 5 6 7
A
NMD upregulated (1.5 fold; in 4 stages; pval=0.003)
0
1
2
b
its
-5
T
-4 -3
T
G
A
-2
C
T
A
-1
T
C
AATG
1 2 3 4 5 6 7
b
its
NMD upregulated (1.7 fold; in 4 stages; pval=0.004)
0
1
2
-5 -4 -3
A
G
-2
T
C
A
-1
C
AATG
1 2 3 4 5 6 7
All transcripts with 5’UTR
0
1
2
b
its
-5 -4
A
-3
T
C
G
A
-2
T
C
A
-1
G
C
AATG
1 2 3 4 5 6 7
In
cr
ea
si
ng
 e
ffe
ct
 o
f N
M
DGenome Biology 2009, 10:R101
http://genomebiology.com/2009/10/9/R101 Genome Biology 2009,     Volume 10, Issue 9, Article R101       Ramani et al. R101.14identification in this way may guide future refinements to
both final gene models and de novo gene-finding algorithms.
Having made a 'reference' wild-type transcriptome, we used
this to examine how this transcriptome is perturbed in worms
lacking a functional NMD pathway. Transcripts containing
PTCs are normally degraded in wild-type animals but will be
retained in NMD mutants and such transcripts will thus be
expressed at higher levels in the mutant. We find that in C.
elegans (as in yeast, fly and human) approximately 10% of
genes have higher expression levels in NMD mutant animals.
First, there is a clear enrichment for the presence of an uORF;
second, such transcripts are more likely to have a long 3' UTR;
third, we see clear evidence for intron retention in many of
these transcripts; and finally, we identify many transcripts
that appear to be direct targets of NMD due to alternative
splicing events. Taken together, we can identify one or more
such features in over 55% of genes that have at least 1.5-fold
increased expression in any single developmental stage in
smg-1(r861) animals. This number rises to over 80% for
genes that have higher expression in the smg-1(r861) mutant
in all four stages. This suggests that most increases in gene
expression seen in smg-1(r861) animals are direct effects of
loss of NMD and that the genes whose expression is increased
in smg-1(r861) mutant animals make PTC-containing tran-
scripts that are normally degraded via NMD.
Identifying genes with perturbed expression in NMD mutants
could have been done using conventional expression arrays
(as was previously done in yeast, fly, and human). Since the
resolution with which we can examine the transcriptome is
far higher using tiling and sequencing, we also investigated
whether other more subtle changes can be seen in the tran-
scriptome of NMD mutant animals. We examined our data to
determine whether we could detect any changes in splicing in
any genes between the wild-type and mutant transcriptomes
that would not have been possible using conventional expres-
sion arrays. We identified a large number of introns that have
increased expression in NMD mutant animals. We infer that
they are likely to be retained in both wild-type and NMD
mutant animals due to inefficient splicing, causing PTCs -
these PTC-containing transcripts are then degraded in wild-
type animals but persist (and hence are present at higher lev-
els) in the NMD mutants. Intriguingly, the retained introns
do not appear to be a random set - fewer of these have the
'TTTCAG' splice site consensus at their 3' end and we thus
suggest that efficiency of excision of introns flanked by splice
sites that closely match the canonical sequences is far higher
than for introns that have more divergent splice sites. In total,
approximately 7% of genes give rise to transcripts with
retained introns - these are usually degraded in wild-type ani-
mals. Overall, however, we find that intron excision is highly
efficient - the vast majority of introns are undetectable in
either wild-type or NMD mutant transcriptomes, and those
that fail to be excised (and hence have elevated levels in NMD
mutants) are usually present at low levels compared with
overall gene expression levels.
Finally, we identified a set of genes that have different iso-
form levels in wild-type and NMD mutant transcriptomes.
Intriguingly, the majority of genes that show a difference in
splicing in the NMD mutants do not differ in overall expres-
sion level between the mutants and the wild-type animals. We
infer from this that the difference in isoform levels in the
mutant is not due to the retention of isoform variants that
contain PTCs (as this would manifest itself in a detectable dif-
ference in expression levels) in the mutants but is instead an
indirect consequence of a loss of NMD. In this case, rather
than the pattern of splicing being identical in wild-type and
mutant and differences in isoform levels being caused by a
loss of NMD in the mutant, the pattern of splicing itself is dif-
ferent between wild-type and mutant. Previous data from a
variety of organisms suggested that some splice factors them-
selves are targets of NMD and indeed we find that approxi-
mately 30% of all well-annotated splice factor genes appear to
make transcripts that are NMD targets. More intriguing is the
finding that genes encoding splicing factors are far more
likely to produce PTC-containing splice variants than random
sets of genes (30% of splice factors, 13% of other genes). This
finding supports the view that alternative splicing and NMD
are two highly interlinked processes [49,50,53,55-61].
We found that many of the splice changes seen in NMD
mutant animals are likely to be indirect consequences of loss
of NMD. Since many genes encoding splice factors are NMD
targets, could this account for the indirect differences in splic-
ing to many other genes seen in NMD mutant animals? We
believe that this may be the case and that this may be the
result of one of two possible effects. One alternative is that the
level of splice factors is perturbed in animals defective for
NMD and that this leads to the many changes in splicing seen
in these mutants. Splice site selection is known to be highly
sensitive to expression levels of splice factors and this is a
plausible explanation. However, we note that although we
detect a difference in overall transcript levels for many splice
factors in NMD mutant animals, this does not imply that the
levels of expressed full-length splice factor proteins differ in
these animals compared with wild-type. The difference in
expression levels of approximately 30% of splice factors in
smg-1(r861) mutants is due to the synthesis of both full-
length encoding transcripts that are stable in both wild-type
and NMD mutant animals and PTC-including transcripts that
are degraded in wild-type animals but not in animals lacking
NMD. We suggest that the retention of these PTC-containing
splice factor-encoding transcripts in smg-1(r861) animals
may result in expression of truncated proteins that interfere
with splice site specification by the full-length splice factors.
The NMD pathway evolved to prevent precisely these kinds of
detrimental effects following the expression of truncated pro-
teins from PTC-containing transcripts. We note that this
model is speculative and that the two alternatives are notGenome Biology 2009, 10:R101
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between these two models.
Intron retention, incorrect exon splicing, and the inheritance
of nonsense mutations all lead to transcripts with PTCs and,
thus, these are all classical targets of NMD. Even if such tran-
scripts were translated, they cannot make full-length protein.
The activation of NMD to degrade a transcript due to the
presence of an uORF in the 5' UTR is more intriguing, how-
ever, since the principal ORF has no premature stops and
thus could be translated. Current models suggest that the
uORF stop is 'seen' by the NMD machinery as premature
since the rest of the transcript is seen as an artificially elon-
gated 'faux' 3' UTR [23,48,62-66] - our data are entirely con-
sistent with this. However, we also find an intriguing
correlation between the sequences surrounding the true ATG
of the main ORF and the levels with which NMD recognizes
uORF-containing transcripts for degradation. Even in tran-
scripts containing an uORF, if the true ATG is surrounded by
sequences that conform closely to a Kozak consensus, and
thus is used efficiently for translational initiation, the tran-
script is less likely to be an NMD target. The effect is slight
and poorly predictive - it does not explain why most tran-
scripts containing an uORF evade NMD, and many other
determinants must affect this. However, it fits well with a
model where a first exploratory round of translation is used to
find the start ATG followed by subsequent rounds of steady-
state translation [67]. If the true ATG is in an excellent initia-
tion consensus, it will be used in subsequent rounds of initia-
tion and the uORF will be translated at a lower rate; hence,
there will be a lower impact of NMD. The relationship
between the efficiency of translational initiation at the true
ATG and the level of NMD targeting suggests that, in tran-
scripts containing a uORF, selection of sequences surround-
ing the true ATG may in some cases fine-tune protein levels
not only by affecting the rates of translational initiation but
also by affecting transcript turnover and hence transcript lev-
els. It will be interesting to see whether this speculative model
holds true as experimentalists studying NMD identify the
exact sequence features that mark out targets of NMD.
Examining the transcriptome of NMD mutant animals has
given us a window into the change in cellular transcription
and transcript processing machinery since we can see all tran-
scripts that are made in the wild-type animals but degraded
by NMD. We find that, in general, transcription in the worm
appears to be very specific - the great majority of transcripts
identified in the NMD mutants are also present in wild-type
animals and are not affected by loss of NMD. The cell thus
does not appear to make a large quantity of aberrant PTC-
containing transcripts. Splicing appears to be slightly more
error-prone, however, with approximately 7% of genes mak-
ing transcripts that are NMD targets due to a failure to excise
introns. Finally, while some changes in splicing lead to PTCs
in transcripts, many of the differences in splicing that we can
detect in NMD mutants could be indirect, resulting from per-
turbations in transcripts encoding splice factors themselves.
The high resolution transcriptome map that we used in this
study was invaluable, allowing us not only to analyze expres-
sion levels of predicted genes, but also to examine each exon
and intron individually as well as to identify novel transcribed
regions. We hope that the availability of this scaffold will help
direct future transcriptome research in C. elegans, in particu-
lar in the analysis of splicing and RNA stability.
Materials and methods
Strain maintenance and RNA preparation and 
processing
C. elegans strains were maintained on NGM agar plates
seeded with OP50 Escherichia coli according to standard pro-
tocols [68]. Strains for which data are presented in this paper
are Bristol N2, smg-1(r861) and smg-5(r860). All strains
were supplied by the Caenorhabditis Genetics Centre (CGC)
[69], University of Minnesota, USA. Total RNA was prepared
using Trizol solution according to the manufacturer's proto-
col, cleaned using Rneasy columns (QIAGEN, Venlo, Lim-
burg, The Netherlands) and Dnase treated for 30 minutes
with 10 U Dnase I (Roche, (Basel, Switzerland) in 1× One-
Phor-All buffer (GE Healthcare, Little Chalfont, Buckingham-
shire, UK). RNA was then re-purified using Rneasy columns
before labeling and hybridizing to Affymetrix GeneChip C.
elegans Tiling 1.0R Arrays as previously described [11,13]. In
the case of sequence data, polyA+ RNA was purified from
total RNA using Oligotex Midi Kits (QIAGEN) according to
the manufacturer's protocol. cDNA was then produced using
SuperScript™ Double-Stranded cDNA Synthesis Kit (Invitro-
gen, Carlsbad, CA, USA) and purified using a QIAGEN PCR
Purification Kit. Sequence data for the resulting cDNA were
then obtained as described by Wilhelm et al. [14].
Processing of tiling microarray data
Raw spot intensity files (.CEL files) were quantile normalized
in R. The normalized data were processed and exported as
.BAR files using Affymetrix Tiling Analysis Software version
1.1 for visualization in Affymetrix Integrated Genome
Browser. A background cutoff was calculated to include the
top 5% of all non-genic probes (relative to WS150) for each
condition and interval analysis then performed in Tiling
Analysis Software to identify transcribed regions (transfrags)
[11,13] above this cutoff. Maxgap and minrun parameters
were set as 35 bp and 70 bp, respectively [11,13]. Genes were
considered expressed if ≥50% of probes were above back-
ground in ≥50% of unique exons. Gene intensities of median
exonic probes above background within filtered exons were
then calculated. Exon intensities used for the splicing analysis
were the median probe intensity of probes above background
in the exons for which ≥50% of probes were above back-
ground.Genome Biology 2009, 10:R101
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NI was calculated for all internal exons (that is, cassette
exons) as defined by WS150 gene annotations. NI for each
exon was calculated as the ratio of expression of the exon rel-
ative to the expression of the gene:
The change in NI between any two stages, called the 'splice
index' (SI), was calculated for each exon - this defines the
change in expression of an exon relative to the expressed gene
between conditions. More specifically:
where Ei is the median probe intensity above background of
the exon, Gi of the gene and t1 and t2 are the different time
points.
Mapping sequence data to the genome
Reads obtained from sequencing were mapped to the genome
using MAQ [43] version 0.6.6. A quality threshold of 30 was
used as cutoff to determine aligned reads. This yields a count
for the number of reads assigned to each nucleotide position
in the genome. Each nucleotide can therefore be given an
intensity score, which is the number of times it occurs in
mapped reads. Gene intensities from sequence data are there-
fore calculated as the median number of reads that map to
each nucleotide for which there is at least one read that corre-
sponds to the given gene. Exon and intron expression are cal-
culated as the median number of reads mapping across the
exon or intron.
Identifying reads mapping to splice sites
To map reads to splice junctions, we created a non-redundant
set of sequences 66 nucleotides long corresponding to all pos-
sible splice junctions (annotated adjacent and non-adjacent
exons based on WS150 were used; see Additional data file 6).
This was created by combining 33 nucleotides from the 3' end
of the upstream exon with 33 nucleotides from the 5' end of
the downstream exon. Sequence reads were first mapped to
the genome and the set of reads that mapped at less than a
quality threshold of '30' by using MAQ were deemed
unmapped. These reads were then aligned to the splice junc-
tions, created as stated above, using BLAT and reads were
identified as mapping to a junction if there was at least a four-
nucleotide overlap over either exonic half of the correspond-
ing junction. Reads that had multiple hits to different junc-
tions were eliminated. Junction sequences formed by
combining non-adjacent exons and having reads mapping to
them uniquely were determined to be alternative splice sites.
Currently, the calls are of a binary nature, with every alterna-
tive junction with reads mapping to it under the above criteria
considered positive calls.
Data access
The raw data can be accessed from two independent loca-
tions. The first is at Wormbase - all the tiling data and
sequence data will be available as a download. The tiling data
are viewable in Wormbase as tracks in the Gene View section.
The sequence data are available from the NCBI Short Read
Archive and the tracking number is SRA009279.
Abbreviations
ENT: endogenous NMD target; MAQ: Mapping and Assem-
bly with Qualities; NI: normalized intensity; NMD: nonsense-
mediated decay; ORF: open reading frame; uORF: upstream
ORF; PTC: premature termination codon; transfrag: tran-
scribed feature; UTR: untranslated region.
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Additional data files
The following additional data files are available with the
online version of this paper: Tables S1 to S8 (Additional data
file 1); a figure showing the distribution of mapped sequence
reads (Additional data file 2); a figure detailing a comparison
of tiling and sequence data for smg-1(r861), which is analo-
gous to Figure 1 for N2 (wild type) (Additional data file 3); a
text file that contains the set of genes that are over-expressed
twofold or more in the NMD mutant compared to wild type
(Additional data file 4); a figure showing the structural
changes in SR gene transcripts between N2 and smg-1(r861)
(Additional data file 5); a fasta file containing all the exon
junction sequences (Additional data file 6).
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